Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1–derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study

Autor: Spertini, François, DellaCorte, Gilles, Kettner, Alexander, de Blay, Frédéric, Jacobsen, Lars, Jutel, Marek, Worm, Margitta, Charlon, Vincent, Reymond, Christophe
Zdroj: In The Journal of Allergy and Clinical Immunology July 2016 138(1):162-168
Databáze: ScienceDirect
Externí odkaz: